Bullish Case: HIBS gained ~28% in a month as high-beta risk-off finally materialized, validating the Oct 10 convexity call. Term structure stays backwardated, bullish option risk exceeds bearish by 51%, Helium's model flags +8.51%, and the market density peaks at $21–25 with a secondary Helium cluster near $25–30. Continued high-beta weakness into December FOMC extends the squeeze.

Bearish Case: A -3x inverse fund up 28% in 30 days is prone to mean-reversion: any high-beta bounce plus vol crush hits doubly. Dec 18 put skew (107–129% IV at 20–26) still prices downside tails, historical return surface shows fat left tails, and backwardated front IV bleeds premium daily. Volume is at the 3rd percentile—thin conviction.

Potential Outcomes:

1. 30%: Continued risk-off into Dec FOMC; HIBS $23–26.
2. 28%: High-beta bounce, vol crush; HIBS $17–19.
3. 22%: Range/decay around $20–22.
4. 12%: Vol-spike tail; HIBS $28–32.
5. 8%: Melt-up risk-on; HIBS $14–16.

November 11, 2026